{"id":42539,"date":"2025-09-30T14:22:48","date_gmt":"2025-09-30T06:22:48","guid":{"rendered":"https:\/\/flcube.com\/?p=42539"},"modified":"2025-09-30T14:22:49","modified_gmt":"2025-09-30T06:22:49","slug":"tj-biopharma-secures-series-c2-funding-to-accelerate-autoimmune-and-oncology-pipeline","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=42539","title":{"rendered":"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline"},"content":{"rendered":"\n<p><strong>China\u2011based TJ Biopharma<\/strong> announced today the successful completion of a <strong>Series\u202fC2 financing round<\/strong> that raised <strong>nearly\u202fRMB\u202f600\u202fmillion<\/strong> (\u2248\u202fUS\u202f$84\u202fmillion). The deal was led by a fund under <strong>CICC Capital<\/strong> and included participation from <strong>Yijing Capital<\/strong> and a host of other institutional investors. Existing shareholders \u2013 <strong>Heda Capital<\/strong> and <strong>Tsing\u202fSong Capital<\/strong> \u2013 also increased their stakes, underscoring confidence in the company\u2019s growth trajectory.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-purpose-of-the-capital-injection\">Purpose of the Capital Injection<\/h3>\n\n\n\n<p>The fresh capital will be deployed primarily to:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Advance Phase\u202f3 clinical trials<\/strong> and <strong>regulatory submissions<\/strong> for TJ\u202fBiopharma\u2019s two flagship candidates, the CD38 antibody <strong>Felzartamab<\/strong> and the long\u2011acting growth\u2011hormone analogue <strong>Eftansomatropin\u202fAlfa<\/strong>.<\/li>\n\n\n\n<li><strong>Accelerate development<\/strong> of its second\u2011tier pipeline of globally innovative drug candidates, leveraging the company\u2019s proprietary <strong>IG\u202fPlus integrated technology platform<\/strong>.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-portfolio-highlights\">Portfolio Highlights<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Felzartamab<\/strong> (CD38 antibody) \u2013 a next\u2011generation therapeutic for multiple myeloma and other plasma\u2011cell disorders.<\/li>\n\n\n\n<li><strong>Eftansomatropin\u202fAlfa<\/strong> \u2013 a long\u2011acting growth\u2011hormone analogue poised for approval in growth\u2011hormone deficiency.<\/li>\n\n\n\n<li><strong>Efmedaglutide\u202fAlfa (TJ103\/TG103)<\/strong> \u2013 a long\u2011acting GLP\u20111 fusion protein developed in partnership with <strong>CSPC\u202fPharma<\/strong>.<\/li>\n\n\n\n<li><strong>Uliledlimab (CD73 antibody)<\/strong> \u2013 a novel immunotherapeutic in collaboration with <strong>Sanofi<\/strong>, currently in clinical trials.<\/li>\n\n\n\n<li><strong>Plonmarlimab<\/strong> \u2013 targeting macrophage\u2011activation syndrome (MAS) and gouty arthritis.<\/li>\n\n\n\n<li><strong>Givastomig (CLDN18.2\u202f\u00d7\u202f4\u20111BB bispecific antibody)<\/strong> \u2013 the first\u2011in\u2011class bispecific designed to engage tumor\u2011associated antigens and costimulatory signals.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-technology-amp-partnerships\">Technology &amp; Partnerships<\/h3>\n\n\n\n<p>TJ\u202fBiopharma\u2019s <strong>IG\u202fPlus platform<\/strong> integrates conditional 4\u20111BB bispecific antibodies and masked peptide prodrugs, providing a modular, scalable approach to drug discovery. The company\u2019s multi\u2011tiered pipeline spans autoimmune diseases, immuno\u2011oncology, and metabolic disorders, positioning it at the forefront of next\u2011generation therapeutics.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-market-outlook\">Market Outlook<\/h3>\n\n\n\n<p>With a robust pipeline and a growing portfolio of partnerships, TJ\u202fBiopharma is poised to capture a sizeable share of the rapidly expanding immuno\u2011oncology and metabolic\u2011disorder markets. The Series\u202fC2 financing strengthens the company\u2019s ability to bring its lead candidates to market, while the second\u2011tier platform accelerates the development of future\u2011generation biologics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China\u2011based TJ Biopharma announced today the successful completion of a Series\u202fC2 financing round that raised&#8230;<\/p>\n","protected":false},"author":1,"featured_media":42540,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[30,20,527],"class_list":["post-42539","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-biotech","tag-finance","tag-tj-biopharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China\u2011based TJ Biopharma announced today the successful completion of a Series\u202fC2 financing round that raised nearly\u202fRMB\u202f600\u202fmillion (\u2248\u202fUS\u202f$84\u202fmillion). The deal was led by a fund under CICC Capital and included participation from Yijing Capital and a host of other institutional investors. Existing shareholders \u2013 Heda Capital and Tsing\u202fSong Capital \u2013 also increased their stakes, underscoring confidence in the company\u2019s growth trajectory.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=42539\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline\" \/>\n<meta property=\"og:description\" content=\"China\u2011based TJ Biopharma announced today the successful completion of a Series\u202fC2 financing round that raised nearly\u202fRMB\u202f600\u202fmillion (\u2248\u202fUS\u202f$84\u202fmillion). The deal was led by a fund under CICC Capital and included participation from Yijing Capital and a host of other institutional investors. Existing shareholders \u2013 Heda Capital and Tsing\u202fSong Capital \u2013 also increased their stakes, underscoring confidence in the company\u2019s growth trajectory.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=42539\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-30T06:22:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-30T06:22:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3004.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline\",\"datePublished\":\"2025-09-30T06:22:48+00:00\",\"dateModified\":\"2025-09-30T06:22:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539\"},\"wordCount\":341,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3004.webp\",\"keywords\":[\"Biotech\",\"Finance\",\"TJ Biopharma\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42539#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=42539\",\"name\":\"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3004.webp\",\"datePublished\":\"2025-09-30T06:22:48+00:00\",\"dateModified\":\"2025-09-30T06:22:49+00:00\",\"description\":\"China\u2011based TJ Biopharma announced today the successful completion of a Series\u202fC2 financing round that raised nearly\u202fRMB\u202f600\u202fmillion (\u2248\u202fUS\u202f$84\u202fmillion). The deal was led by a fund under CICC Capital and included participation from Yijing Capital and a host of other institutional investors. Existing shareholders \u2013 Heda Capital and Tsing\u202fSong Capital \u2013 also increased their stakes, underscoring confidence in the company\u2019s growth trajectory.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42539\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3004.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3004.webp\",\"width\":1080,\"height\":608,\"caption\":\"TJ\u202fBiopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42539#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline - Insight, China&#039;s Pharmaceutical Industry","description":"China\u2011based TJ Biopharma announced today the successful completion of a Series\u202fC2 financing round that raised nearly\u202fRMB\u202f600\u202fmillion (\u2248\u202fUS\u202f$84\u202fmillion). The deal was led by a fund under CICC Capital and included participation from Yijing Capital and a host of other institutional investors. Existing shareholders \u2013 Heda Capital and Tsing\u202fSong Capital \u2013 also increased their stakes, underscoring confidence in the company\u2019s growth trajectory.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=42539","og_locale":"en_US","og_type":"article","og_title":"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline","og_description":"China\u2011based TJ Biopharma announced today the successful completion of a Series\u202fC2 financing round that raised nearly\u202fRMB\u202f600\u202fmillion (\u2248\u202fUS\u202f$84\u202fmillion). The deal was led by a fund under CICC Capital and included participation from Yijing Capital and a host of other institutional investors. Existing shareholders \u2013 Heda Capital and Tsing\u202fSong Capital \u2013 also increased their stakes, underscoring confidence in the company\u2019s growth trajectory.","og_url":"https:\/\/flcube.com\/?p=42539","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-30T06:22:48+00:00","article_modified_time":"2025-09-30T06:22:49+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3004.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=42539#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=42539"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline","datePublished":"2025-09-30T06:22:48+00:00","dateModified":"2025-09-30T06:22:49+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=42539"},"wordCount":341,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=42539#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3004.webp","keywords":["Biotech","Finance","TJ Biopharma"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=42539#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=42539","url":"https:\/\/flcube.com\/?p=42539","name":"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=42539#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=42539#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3004.webp","datePublished":"2025-09-30T06:22:48+00:00","dateModified":"2025-09-30T06:22:49+00:00","description":"China\u2011based TJ Biopharma announced today the successful completion of a Series\u202fC2 financing round that raised nearly\u202fRMB\u202f600\u202fmillion (\u2248\u202fUS\u202f$84\u202fmillion). The deal was led by a fund under CICC Capital and included participation from Yijing Capital and a host of other institutional investors. Existing shareholders \u2013 Heda Capital and Tsing\u202fSong Capital \u2013 also increased their stakes, underscoring confidence in the company\u2019s growth trajectory.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=42539#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=42539"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=42539#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3004.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3004.webp","width":1080,"height":608,"caption":"TJ\u202fBiopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=42539#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"TJ Biopharma Secures Series\u202fC2 Funding to Accelerate Autoimmune and Oncology Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3004.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42539"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42539\/revisions"}],"predecessor-version":[{"id":42541,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42539\/revisions\/42541"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/42540"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42539"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}